Chronic opioid therapy modifies QST changes following ketamine infusion in chronic pain patients.

about

Chronic opioid therapy modifies QST changes following ketamine infusion in chronic pain patients.

Item

http://www.wikidata.org/entity/Q38627481

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chronic opioid therapy modifie ...... sion in chronic pain patients.

@en

type

Item

label

Chronic opioid therapy modifie ...... sion in chronic pain patients.

@en

prefLabel

Chronic opioid therapy modifie ...... sion in chronic pain patients.

@en

P1476

Chronic Opioid Therapy Modifie ...... usion in Chronic Pain Patients

@en

P2093

Charlene Malarick

http://www.w3.org/2001/XMLSchema#string

Dermot P Maher

http://www.w3.org/2001/XMLSchema#string

Jianren Mao

http://www.w3.org/2001/XMLSchema#string

Kristin Stabach

http://www.w3.org/2001/XMLSchema#string

Lucy Chen

http://www.w3.org/2001/XMLSchema#string

Shihab Ahmed

http://www.w3.org/2001/XMLSchema#string

Yi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy

Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients.

Neuropathic central pain: epidemiology, etiology, and treatment options.

Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain.

Chronic opioid potentiates presynaptic but impairs postsynaptic N-methyl-D-aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance.

Altered quantitative sensory testing outcome in subjects with opioid therapy.

Pharmacotherapy for pain: efficacy and safety issues examined by subgroup analyses.

Opioid-induced hyperalgesia: Cellular and molecular mechanisms.

P304

1468-1475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPAIN.2017.07.008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tina L Doshi

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28802882

http://www.w3.org/2001/XMLSchema#string

P921

chronic pain

P932

5729746

http://www.w3.org/2001/XMLSchema#string